Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), a multi-modal image database that aims to boost ...

This week the University of Liverpool launched the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), an ...

CVRM product development global head and senior vice-president Manu Chakravarthy will be the centre's site head.

Basel: Roche has announced that it has entered into an exclusive collaboration and licensing agreement with Zealand Pharma.

Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, March 11, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, ...

Inventions made in a particular country are generally first-filed in that country before entering the United States via a direct Paris ...

The POC Diagnostics Market is expected to grow from an estimated USD 51.26 billion in 2024 to USD 118.91 billion in 2033, at a CAGR of 9.8%. The global point-of-care (POC) diagnostics market is ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

Roche and its Genentech subsidiary are planning to hitch up their cardiovascular, renal and metabolism R&D work and shift it over to a new center in Harvard’s Enterprise Research Campus. | Roche and ...

Pharmaceutical giant Roche announces opening of an innovation centre at Harvard University's corporate research campus.